Janssen, J. J. W. M. http://orcid.org/0000-0001-9567-1955
Löwenberg, B.
Manz, M. http://orcid.org/0000-0002-4676-7931
Biemond, B. J.
Westerweel, P. E. http://orcid.org/0000-0002-0746-7039
Klein, S. K. http://orcid.org/0000-0001-8847-2704
Fehr, M.
Sinnige, H. A. M.
Efthymiou, A.
Legdeur, M. C. J. C.
Pabst, T. http://orcid.org/0000-0002-6055-5257
Gregor, M.
van der Poel, M. W. M.
Deeren, D.
Tick, L. W. http://orcid.org/0000-0002-0771-5231
Jongen-Lavrencic, M.
van Obbergh, F.
Boersma, R. S.
de Weerdt, O.
Chalandon, Y. http://orcid.org/0000-0001-9341-8104
Heim, D.
Spertini, O. http://orcid.org/0000-0002-1669-9421
van Sluis, G.
Graux, C.
Stüssi, G.
van Norden, Y.
Ossenkoppele, G. J.
Article History
Received: 24 May 2022
Revised: 7 July 2022
Accepted: 13 July 2022
First Online: 22 July 2022
Conflict of interest
: JJWMJ: Research support: Novartis, BMS. President, Apps for Care and Science, nonprofit foundation supported by Abbvie, Alexion, Amgen, Astellas, BMS, Daiichi-Sankyo, Janssen-Cilag, Olympus, Incyte, Sanofi Genzyme, Servier, Jazz, Takeda. Honoraria: Abbvie, Novartis, Pfizer, Incyte. BL: Advisory role with honoraria for AbbVie, Astellas, Bristol Myers Squibb/Celgene, Catamaran Bio, Celgene, AvenCell/GeMoaB, Frame Pharmaceuticals, Gilead, Kronos Bio, Oxford Biomedica, Servier, holding stocks of Frame Pharmaceuticals. YC: consulting fees from MSD, Novartis, Incyte, BMS, Pfizer, Abbvie, Roche, Jazz, Gilead, Amgen, Astra-Zeneca Servier; Travel support from MSD, Roche, Gilead, Amgen, Incyte, Abbvie, Janssen, Astra-Zeneca, Jazz. GJO: Research support: Novartis, J&J, Celgene, Becton Dickinson; Consultancy: J&J, Sunesis, Celgene, Roche; Advisory board: Novartis, Pfizer, BMS, J&J, Sunesis, Celgene, Agios, Amgen, Astellas, Roche, Jazz Pharmaceuticals, Merus. <b>Others</b>: None declared. The funders had no role in the design of the study, nor in the collection, analyses, or interpretation of data, nor in the writing of the manuscript, or in the decision to publish the results.